117 related articles for article (PubMed ID: 38692174)
41. Monocarboxylate transporters in breast cancer and adipose tissue are novel biomarkers and potential therapeutic targets.
Li Z; Wu Q; Sun S; Wu J; Li J; Zhang Y; Wang C; Yuan J; Sun S
Biochem Biophys Res Commun; 2018 Jul; 501(4):962-967. PubMed ID: 29775610
[TBL] [Abstract][Full Text] [Related]
42. In Vitro and In Vivo Efficacy of AZD3965 and Alpha-Cyano-4-Hydroxycinnamic Acid in the Murine 4T1 Breast Tumor Model.
Guan X; Morris ME
AAPS J; 2020 Jun; 22(4):84. PubMed ID: 32529599
[TBL] [Abstract][Full Text] [Related]
43. Valproic acid transport in the choriocarcinoma placenta cell line JEG-3 proceeds independently of the proton-dependent transporters MCT1 and MCT4.
Ishiguro Y; Furugen A; Narumi K; Nishimura A; Hirano T; Kobayashi M; Iseki K
Drug Metab Pharmacokinet; 2018 Dec; 33(6):270-274. PubMed ID: 30341000
[TBL] [Abstract][Full Text] [Related]
44. CD147 regulates the expression of MCT1 and lactate export in multiple myeloma cells.
Walters DK; Arendt BK; Jelinek DF
Cell Cycle; 2013 Oct; 12(19):3175-83. PubMed ID: 24013424
[TBL] [Abstract][Full Text] [Related]
45. BRCA1 mutations drive oxidative stress and glycolysis in the tumor microenvironment: implications for breast cancer prevention with antioxidant therapies.
Martinez-Outschoorn UE; Balliet R; Lin Z; Whitaker-Menezes D; Birbe RC; Bombonati A; Pavlides S; Lamb R; Sneddon S; Howell A; Sotgia F; Lisanti MP
Cell Cycle; 2012 Dec; 11(23):4402-13. PubMed ID: 23172369
[TBL] [Abstract][Full Text] [Related]
46. Regulation of human monocarboxylate transporter 4 in skeletal muscle cells: the role of protein kinase C (PKC).
Narumi K; Kobayashi M; Otake S; Furugen A; Takahashi N; Ogura J; Itagaki S; Hirano T; Yamaguchi H; Iseki K
Int J Pharm; 2012 May; 428(1-2):25-32. PubMed ID: 22426323
[TBL] [Abstract][Full Text] [Related]
47. Butyrate activates the monocarboxylate transporter MCT4 expression in breast cancer cells and enhances the antitumor activity of 3-bromopyruvate.
Queirós O; Preto A; Pacheco A; Pinheiro C; Azevedo-Silva J; Moreira R; Pedro M; Ko YH; Pedersen PL; Baltazar F; Casal M
J Bioenerg Biomembr; 2012 Feb; 44(1):141-53. PubMed ID: 22350013
[TBL] [Abstract][Full Text] [Related]
48. Smart Polymeric Nanoparticles with pH-Responsive and PEG-Detachable Properties (II): Co-Delivery of Paclitaxel and VEGF siRNA for Synergistic Breast Cancer Therapy in Mice.
Jin M; Hou Y; Quan X; Chen L; Gao Z; Huang W
Int J Nanomedicine; 2021; 16():5479-5494. PubMed ID: 34413645
[TBL] [Abstract][Full Text] [Related]
49. Oncogenes and inflammation rewire host energy metabolism in the tumor microenvironment: RAS and NFκB target stromal MCT4.
Martinez-Outschoorn UE; Curry JM; Ko YH; Lin Z; Tuluc M; Cognetti D; Birbe RC; Pribitkin E; Bombonati A; Pestell RG; Howell A; Sotgia F; Lisanti MP
Cell Cycle; 2013 Aug; 12(16):2580-97. PubMed ID: 23860378
[TBL] [Abstract][Full Text] [Related]
50. Oxygen tension controls the expression of the monocarboxylate transporter MCT4 in cultured mouse cortical astrocytes via a hypoxia-inducible factor-1α-mediated transcriptional regulation.
Rosafio K; Pellerin L
Glia; 2014 Mar; 62(3):477-90. PubMed ID: 24375723
[TBL] [Abstract][Full Text] [Related]
51. Loss of caveolin-1 and gain of MCT4 expression in the tumor stroma: key events in the progression from an in situ to an invasive breast carcinoma.
Martins D; Beça FF; Sousa B; Baltazar F; Paredes J; Schmitt F
Cell Cycle; 2013 Aug; 12(16):2684-90. PubMed ID: 23907124
[TBL] [Abstract][Full Text] [Related]
52. Therapy-induced DNA methylation inactivates MCT1 and renders tumor cells vulnerable to MCT4 inhibition.
Vander Linden C; Corbet C; Bastien E; Martherus R; Guilbaud C; Petit L; Wauthier L; Loriot A; De Smet C; Feron O
Cell Rep; 2021 Jun; 35(9):109202. PubMed ID: 34077729
[TBL] [Abstract][Full Text] [Related]
53. Prognostic value of monocarboxylate transporter 4 in patients with esophageal squamous cell carcinoma.
Cheng B; Chen X; Li Y; Huang X; Yu J
Oncol Rep; 2018 Nov; 40(5):2906-2915. PubMed ID: 30226548
[TBL] [Abstract][Full Text] [Related]
54. A Holistic Evolutionary and 3D Pharmacophore Modelling Study Provides Insights into the Metabolism, Function, and Substrate Selectivity of the Human Monocarboxylate Transporter 4 (hMCT4).
Papakonstantinou E; Vlachakis D; Thireou T; Vlachoyiannopoulos PG; Eliopoulos E
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805725
[TBL] [Abstract][Full Text] [Related]
55. Combination antitumor immunotherapy with VEGF and PIGF siRNA via systemic delivery of multi-functionalized nanoparticles to tumor-associated macrophages and breast cancer cells.
Song Y; Tang C; Yin C
Biomaterials; 2018 Dec; 185():117-132. PubMed ID: 30241030
[TBL] [Abstract][Full Text] [Related]
56. The monocarboxylate transporter 4 is required for glycolytic reprogramming and inflammatory response in macrophages.
Tan Z; Xie N; Banerjee S; Cui H; Fu M; Thannickal VJ; Liu G
J Biol Chem; 2015 Jan; 290(1):46-55. PubMed ID: 25406319
[TBL] [Abstract][Full Text] [Related]
57. MCT4 as a potential therapeutic target to augment gemcitabine chemosensitivity in resected pancreatic cancer.
Lee SH; Hwang HK; Lee WJ; Kang CM
Cell Oncol (Dordr); 2021 Dec; 44(6):1363-1371. PubMed ID: 34791637
[TBL] [Abstract][Full Text] [Related]
58. High glucose and interleukin 1β-induced apoptosis in human umbilical vein endothelial cells involves in down-regulation of monocarboxylate transporter 4.
Wang D; Wang Q; Yan G; Qiao Y; Sun L; Zhu B; Tang C; Gu Y
Biochem Biophys Res Commun; 2015 Oct; 466(4):607-14. PubMed ID: 26363456
[TBL] [Abstract][Full Text] [Related]
59. The relationship between the expressions of tumor associated fibroblasts Cav-1 and MCT4 and the prognosis of papillary carcinoma of breast.
Zhai Y; Chai L; Chen J
Pak J Pharm Sci; 2017 Jan; 30(1 Suppl):263-272. PubMed ID: 28625953
[TBL] [Abstract][Full Text] [Related]
60. DNA methylation of the SLC16A3 promoter regulates expression of the human lactate transporter MCT4 in renal cancer with consequences for clinical outcome.
Fisel P; Kruck S; Winter S; Bedke J; Hennenlotter J; Nies AT; Scharpf M; Fend F; Stenzl A; Schwab M; Schaeffeler E
Clin Cancer Res; 2013 Sep; 19(18):5170-81. PubMed ID: 23881922
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
